Sulai Liu
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC Hepatocellular Carcinoma | Phase 2 | 2024-03-03 |
| Unknown | Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Hepatocellular Carcinoma | N/A | 2022-08-01 |